|
|
| Line 35: |
Line 35: |
|
| |
|
| === [[hasPatientGuides::Compilation:_ESMO_Patient_Guides_(Luxembourg)|Compilation: ESMO Patient Guides]] === | | === [[hasPatientGuides::Compilation:_ESMO_Patient_Guides_(Luxembourg)|Compilation: ESMO Patient Guides]] === |
|
| |
| '''Sponsor, manager or home institution:''' European Society for Medical Oncology.
| |
|
| |
| '''Primary purpose:''' To translate complex medical language into understandable information for patients.
| |
|
| |
| '''Available guides:''' Cancer Treatment During the COVID-19 Pandemic; Immunotherapy Side Effects and Their Management; Personalized Medicine; Survival; Colorectal Cancer; Endometrial Cancer; Stomach Cancer; Gliomas; AML; CML; Follicular Lymphoma; Bone Sarcomas; Non-Small Cell Lung Cancer (NSCLC); Head and Neck Cancer; Soft Tissue Sarcomas.
| |
|
| |
| '''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.
| |
|
| |
| '''Access to information:''' List of guides [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-french].
| |
| </div> | | </div> |
|
| |
|
